Bausch Health has one solution on long-term back order and another discontinued in October, Zydus Pharmaceuticals USA has one solution with a short expiration backordered, and Cameron Pharmaceuticals could not provide information to the ASHP.
Zydus said it expects resupply to happen in the second half of 2023, and Bausch said it could not predict a release date.
